Company profile CRIS
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Curis, Inc. expected interest is significantly lower compared to previous quarter (-100.0%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 242 inf% QoQ | 73 -69.8% QoQ | 30 -58.9% QoQ |
| 2020 | 73 inf% YoY 143.3% QoQ | 141 -41.7% YoY 93.2% QoQ | 89 21.9% YoY -36.9% QoQ | 72 140.0% YoY -19.1% QoQ |
| 2021 | 135 84.9% YoY 87.5% QoQ | 114 -19.1% YoY -15.6% QoQ | 81 -9.0% YoY -28.9% QoQ | 99 37.5% YoY 22.2% QoQ |
| 2022 | 176 30.4% YoY 77.8% QoQ | 111 -2.6% YoY -36.9% QoQ | 64 -21.0% YoY -42.3% QoQ | 70 -29.3% YoY 9.4% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 56 -49.5% YoY inf% QoQ | 176 175.0% YoY 214.3% QoQ | 52 -25.7% YoY -70.5% QoQ |
| 2024 | 0 -25.7% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Curis, Inc. was 7.1 per week. The last year interest of Curis, Inc. compared to the last 5 years has changed by -23.1%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -17.65%.
There is not enough data for Curis cancer drug to provide analysis
There is not enough data for Curis cancer drug to provide correlation calculation
There is not enough data for Curis cancer drug to provide analysis
There is not enough data for Curis Emavusertib to provide analysis
There is not enough data for Curis Emavusertib to provide correlation calculation
There is not enough data for Curis Emavusertib to provide analysis
There is not enough data for Curis CI-8993 to provide analysis
There is not enough data for Curis CI-8993 to provide correlation calculation
There is not enough data for Curis CI-8993 to provide analysis
There is not enough data for Curis Fimepinostat to provide analysis
There is not enough data for Curis Fimepinostat to provide correlation calculation
There is not enough data for Curis Fimepinostat to provide analysis
There is not enough data for Curis CA-170 to provide analysis
There is not enough data for Curis CA-170 to provide correlation calculation
There is not enough data for Curis CA-170 to provide analysis
There is not enough data for Curis cancer treatment to provide analysis
There is not enough data for Curis cancer treatment to provide correlation calculation
There is not enough data for Curis cancer treatment to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Curis stock price expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 49 | 26 -46.9% QoQ | 0 -100.0% QoQ | 63 inf% QoQ |
| 2020 | 76 55.1% YoY 20.6% QoQ | 44 69.2% YoY -42.1% QoQ | 34 inf% YoY -22.7% QoQ | 162 157.1% YoY 376.5% QoQ |
| 2021 | 80 5.3% YoY -50.6% QoQ | 172 290.9% YoY 115.0% QoQ | 114 235.3% YoY -33.7% QoQ | 43 -73.5% YoY -62.3% QoQ |
| 2022 | 73 -8.8% YoY 69.8% QoQ | 100 -41.9% YoY 37.0% QoQ | 48 -57.9% YoY -52.0% QoQ | 45 4.7% YoY -6.2% QoQ |
| 2023 | 62 -15.1% YoY 37.8% QoQ | 0 -100.0% YoY -100.0% QoQ | 36 -25.0% YoY inf% QoQ | 36 -20.0% YoY 0.0% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Curis stock price was 4.84 per week. The last year interest of Curis stock price compared to the last 5 years has changed by -65.91%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -54.17%.
There is not enough data for Curis clinical trials to provide analysis
There is not enough data for Curis clinical trials to provide correlation calculation
There is not enough data for Curis clinical trials to provide analysis
There is not enough data for Curis careers to provide analysis
There is not enough data for Curis careers to provide correlation calculation
There is not enough data for Curis careers to provide analysis